课题基金 / 基金详情

Treatment of Rheumatoid Arthritis-Marine/Botanical Oils

Treatment of Rheumatoid Arthritis-Marine/Botanical Oils
类风湿关节炎的治疗-海洋/植物油
批准号:
6581789
负责人:
ROBERT B ZURIER
金额:
$55.11万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2007-05-31

项目摘要

项目成果

ROBERT B ZURIER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The object of this proposal is to determine whether treatment of rheumatoid arthritis (RA) with a combination of fish oil and borage seed oil is superior to treatment with either oil alone. Fish oil is rich in the antiinflammatory n3 unsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and borage oil contains gammalinolenic acid (GLA), an n6 unsaturated fatty acid with antiinflammatory and immunomodulatory properties. Administration of borage oil and of fish oil both suppress the clinical manifestations of RA. Animal studies indicate that the mechanisms whereby fish oil suppresses inflammation are both similar to and different from the means by which GLA reduces inflammation and that the combination treatment is more effective than each treatment alone. This proposal is for a multi-center, two-year, phase 3, double-masked, placebo-controlled trial of 375 patients, which includes 4 treatment groups: 1) corn oil as a polyunsaturated fatty acid control; 2) fish oil; 3) borage oil; 4) fish oil plus borage oil. Radiographic analysis (Sharp Scores) of hands and feet will be done at baseline, 12, and 24 months. Biochemical and molecular mechanisms whereby the fatty acid treatments influence activation of monocytes (cytokine and oxygen radical generation), and T lymphocytes (proliferation, cytokine production, Th1/Th2 skewing, signaling events) will be investigated. Results of the cell activation (ex vivo) studies will be correlated with clinical outcomes. Results of these studies should raise awareness of the usefulness of naturally occurring oils in inflammatory diseases, lead to more rational use of fatty acids in treatment of inflammatory arthritis, and provide a greater understanding of the mechanisms of action of antiinflammatory fatty acids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Nonpsychotropic Cannabinoid Agonist for the Treatment of Sclerod
  • 批准号:
    8353713
  • 项目类别:
  • 资助金额:
    $29.44万
  • 财政年份:
    2012
  • 负责人:
    ROBERT B ZURIER
  • 依托单位:
Anti-Inflammatory Properties of Cannabis Constituents
Treatment of Rheumatoid Arthritis-Marine/Botanical Oils
Treatment of Rheumatoid Arthritis-Marine/Botanical Oils
海外基金